ArticleBioinformatics (Oxford, England)2026
MR-MAS: an end-to-end multi-agent system for autonomous Mendelian randomization analysis.
Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
motivationUnderstanding disease-related causal mechanisms is essential for biomedical research, yet the practical use of Mendelian Randomization (MR) remains constrained by fragmented analytical workflows and a strong dependence on specialized expertise. These challenges limit the efficient, standardized, and reproducible execution of end-to-end MR analyses.
resultsWe propose MR-MAS, an end-to-end automated MR analysis system built on a multi-agent architecture. MR-MAS leverages the reasoning and coordination capabilities of large language models (LLMs) and integrates external tools to unify data acquisition, causal effect estimation, results interpretation, and manuscript preparation into a single workflow, thereby reducing manual effort. MR-MAS further incorporates a structured Mendelian Randomization Knowledge Base (MRKB) to support MR method implementation and targeted repair of MR analysis code. Across diverse test scenarios, MR-MAS demonstrated stable workflow execution, reproduced several literature-supported causal signals, and maintained consistent causal estimates across repeated runs and different model backends. Additional evaluations showed robust trait retrieval and improved code-repair performance with MRKB guidance. These results suggest that MR-MAS may provide practical support for scalable, standardized, and reproducible MR analyses in biomedical research. AVAILABILITY AND IMPLEMENTATION: The source code, MRKB, and benchmark data are freely available at https://github.com/Zaiwen/MR-MAS, with the version used in this study archived at https://doi.org/10.5281/zenodo.20342636.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.